208 related articles for article (PubMed ID: 25288747)
41. Osmotic shock induces G1 arrest through p53 phosphorylation at Ser33 by activated p38MAPK without phosphorylation at Ser15 and Ser20.
Kishi H; Nakagawa K; Matsumoto M; Suga M; Ando M; Taya Y; Yamaizumi M
J Biol Chem; 2001 Oct; 276(42):39115-22. PubMed ID: 11495913
[TBL] [Abstract][Full Text] [Related]
42. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.
Grönroos E; Terentiev AA; Punga T; Ericsson J
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12165-70. PubMed ID: 15295102
[TBL] [Abstract][Full Text] [Related]
43. Human EHMT2/G9a activates p53 through methylation-independent mechanism.
Rada M; Vasileva E; Lezina L; Marouco D; Antonov AV; Macip S; Melino G; Barlev NA
Oncogene; 2017 Feb; 36(7):922-932. PubMed ID: 27452519
[TBL] [Abstract][Full Text] [Related]
44. p85α mediates p53 K370 acetylation by p300 and regulates its promoter-specific transactivity in the cellular UVB response.
Song L; Gao M; Dong W; Hu M; Li J; Shi X; Hao Y; Li Y; Huang C
Oncogene; 2011 Mar; 30(11):1360-71. PubMed ID: 21057544
[TBL] [Abstract][Full Text] [Related]
45. Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death.
Lee JH; Kim HS; Lee SJ; Kim KT
J Cell Sci; 2007 Jul; 120(Pt 13):2259-71. PubMed ID: 17591690
[TBL] [Abstract][Full Text] [Related]
46. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
47. Binding and modulation of p53 by p300/CBP coactivators.
Lill NL; Grossman SR; Ginsberg D; DeCaprio J; Livingston DM
Nature; 1997 Jun; 387(6635):823-7. PubMed ID: 9194565
[TBL] [Abstract][Full Text] [Related]
48. Inositol polyphosphate multikinase is a coactivator of p53-mediated transcription and cell death.
Xu R; Sen N; Paul BD; Snowman AM; Rao F; Vandiver MS; Xu J; Snyder SH
Sci Signal; 2013 Apr; 6(269):ra22. PubMed ID: 23550211
[TBL] [Abstract][Full Text] [Related]
49. HSP27 regulates p53 transcriptional activity in doxorubicin-treated fibroblasts and cardiac H9c2 cells: p21 upregulation and G2/M phase cell cycle arrest.
Venkatakrishnan CD; Dunsmore K; Wong H; Roy S; Sen CK; Wani A; Zweier JL; Ilangovan G
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1736-44. PubMed ID: 18263706
[TBL] [Abstract][Full Text] [Related]
50. CCDC134 interacts with hADA2a and functions as a regulator of hADA2a in acetyltransferase activity, DNA damage-induced apoptosis and cell cycle arrest.
Huang J; Zhang L; Liu W; Liao Q; Shi T; Xiao L; Hu F; Qiu X
Histochem Cell Biol; 2012 Jul; 138(1):41-55. PubMed ID: 22644376
[TBL] [Abstract][Full Text] [Related]
51. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.
Lagger G; Doetzlhofer A; Schuettengruber B; Haidweger E; Simboeck E; Tischler J; Chiocca S; Suske G; Rotheneder H; Wintersberger E; Seiser C
Mol Cell Biol; 2003 Apr; 23(8):2669-79. PubMed ID: 12665570
[TBL] [Abstract][Full Text] [Related]
52. ZBTB2, a novel master regulator of the p53 pathway.
Jeon BN; Choi WI; Yu MY; Yoon AR; Kim MH; Yun CO; Hur MW
J Biol Chem; 2009 Jul; 284(27):17935-46. PubMed ID: 19380588
[TBL] [Abstract][Full Text] [Related]
53. An ATM- and Rad3-related (ATR) signaling pathway and a phosphorylation-acetylation cascade are involved in activation of p53/p21Waf1/Cip1 in response to 5-aza-2'-deoxycytidine treatment.
Wang H; Zhao Y; Li L; McNutt MA; Wu L; Lu S; Yu Y; Zhou W; Feng J; Chai G; Yang Y; Zhu WG
J Biol Chem; 2008 Feb; 283(5):2564-74. PubMed ID: 17977830
[TBL] [Abstract][Full Text] [Related]
54. Induction of p53-dependent activation of the human proliferating cell nuclear antigen gene in chromatin by ionizing radiation.
Shan B; Xu J; Zhuo Y; Morris CA; Morris GF
J Biol Chem; 2003 Nov; 278(45):44009-17. PubMed ID: 12947108
[TBL] [Abstract][Full Text] [Related]
55. Monocytic leukemia zinc finger (MOZ) interacts with p53 to induce p21 expression and cell-cycle arrest.
Rokudai S; Aikawa Y; Tagata Y; Tsuchida N; Taya Y; Kitabayashi I
J Biol Chem; 2009 Jan; 284(1):237-244. PubMed ID: 19001415
[TBL] [Abstract][Full Text] [Related]
56. p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG.
Thakur VS; Ruhul Amin AR; Paul RK; Gupta K; Hastak K; Agarwal MK; Jackson MW; Wald DN; Mukhtar H; Agarwal ML
Cancer Lett; 2010 Oct; 296(2):225-32. PubMed ID: 20444544
[TBL] [Abstract][Full Text] [Related]
57. p21 (CDKN1A) is a negative regulator of p53 stability.
Broude EV; Demidenko ZN; Vivo C; Swift ME; Davis BM; Blagosklonny MV; Roninson IB
Cell Cycle; 2007 Jun; 6(12):1468-71. PubMed ID: 17585201
[TBL] [Abstract][Full Text] [Related]
58. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
[TBL] [Abstract][Full Text] [Related]
59. Negative regulation of the p300-p53 interplay by DDX24.
Shi D; Dai C; Qin J; Gu W
Oncogene; 2016 Jan; 35(4):528-36. PubMed ID: 25867071
[TBL] [Abstract][Full Text] [Related]
60. Loss of IKKbeta activity increases p53 stability and p21 expression leading to cell cycle arrest and apoptosis.
Yang PM; Huang WC; Lin YC; Huang WY; Wu HA; Chen WL; Chang YF; Chou CW; Tzeng CC; Chen YL; Chen CC
J Cell Mol Med; 2010 Mar; 14(3):687-98. PubMed ID: 19243472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
